Top 10 sur­pris­es for bio­phar­ma in 2020? Cowen's biotech team of­fers a few ideas to chew on

It’s that time of year when peo­ple in the in­dus­try start pay­ing close at­ten­tion to the pos­si­bil­i­ties of what might hap­pen in 2020. Cowen wants to seed that con­ver­sa­tion with its own pre­dic­tions of what lies ahead, with a top 10 list that starts out as most prob­a­ble and ends by en­ter­ing the po­lit­i­cal realm, where seem­ing­ly any­thing can hap­pen.

Let’s get to it.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER